Dr. Sven Jungmann

We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.

Sventure Capital is a personal holding company with equity positions in healthcare innovation and impact ventures. We maintain a portfolio of participations acquired through various arrangements including capital contributions, sweat equity, founder shares, and advisory engagements. Our holdings focus exclusively on: - Healthcare technology and innovation - Impact-driven ventures with measurable social benefit - Early-stage companies with transformative potential As a personal vehicle, we support our portfolio companies through: - Strategic guidance and advisory input - Operational expertise and network access - Follow-on capital when aligned with company needs - Long-term partnership approach Each participation reflects our commitment to advancing healthcare innovation and creating lasting impact. We take a hands-on approach with our holdings, providing strategic support beyond capital to help founding teams achieve their vision. Current portfolio includes equity positions in companies advancing AI in healthcare health, medical technology, medical education, and regulatory compliance solutions. Note: Sventure Capital operates as a personal holding company managing private equity participations.

Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times. Aiomics changes this. Our AI-driven co-pilot captures every clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable. We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside. Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place. Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer [to be announced soon] who scaled one of Europe’s largest digitally enabled hospitality companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.

Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, Paris, Madison, Seattle, Estonia, Berlin, and Melbourne. The program combines 5 elements to help companies transition from science projects to scalable and financeable companies: - An emphasis on objective-setting, helping companies focus on what’s most important to their business - Focused mentorship from experienced entrepreneurs who have founded, led, and sold significant tech companies - Technical advice from world-leading scientists, engineers, and economists - Hands-on support from top business students, who embed within the company to provide business support - Opportunities to raise capital, including angels and VCs from Europe and North America The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over CAD $35 billion in equity value.

Investec’s Investment Banking group assists entrepreneurs & founders, family businesses, private equity and corporates in selling, buying and financing businesses at best terms. Our 300+ strong investment bankers team invests significant time in the following sectors to shape the best possible outcome for you: Business Services – Consumer – Energy & Infrastructure – Financial Services – Food & Agri – Healthcare – Industrials – TMT. Investec (dual listed on the London, FTSE-250 and Johannesburg Stock Exchanges) is an international banking and wealth management group in Europe, the United States, Southern Africa and Asia-Pacific. Investec is a purpose-driven organisation, dedicated to its core purpose of creating enduring worth, striving to create long-term value for all stakeholders and contribute meaningfully to people, communities and the planet. For more information, please visit: https://www.investec.com/advisory

We bring an Out of the Ordinary approach to creating and managing wealth. Founded in South Africa as a small finance company, today we offer clients our services as a global bank and asset management group. Follow us on LinkedIn for unique insights from leading minds within the world of finance and Out of the Ordinary stories about our people, communities and partners.